Description
KPV is a tiny three-amino-acid peptide (lysine-proline-valine) derived from alpha-melanocyte-stimulating hormone (α-MSH). Studied heavily for its potential to calm tissue inflammation, support gut health, and ease skin irritation without causing unwanted pigmentation, KPV remains unapproved by the FDA for human clinical use. [
What KPV Does in Preclinical Research
- Inflammation Control: Lab and animal models show KPV blocks NF-κB (a master switch for inflammation) and lowers the release of inflammatory cytokines.
- Gut Support: Preclinical tests suggest it targets intestinal tissues via the PepT1 transporter to soothe colitis and support the gut barrier.
- Skin Health: Applied topically or in cell models, it is investigated for reducing redness and irritation associated with dermatitis, eczema, or minor wounds
